Profil
Jerry Cacia worked as the Global Head of Pharmaceutical Technical Development at Genentech, Inc. from 1988 to 2016.
He then served as the Head of Biologics & Drug Product Manufacturing at F.
Hoffmann-La Roche Ltd. from 2016 to 2021.
Currently, he is the Chief Technical Officer at Graphite Bio, Inc. since 2021.
Mr. Cacia completed his undergraduate degree at the University of California, Santa Cruz.
Tidigare kända positioner av Jerry Cacia
| Företag | Position | Slut |
|---|---|---|
| LENZ THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2023-11-01 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | 2021-02-01 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Teknisk/Vetenskaplig/F&U Direktör | - |
Jerry Cacias utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of California, Santa Cruz
University of California, Santa Cruz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Graphite Bio, Inc.
Graphite Bio, Inc. BiotechnologyHealth Technology Operates as gene editing company for DNA integrations | Health Technology |
















